Haya Therapeutics Unveils CRISPR-Based Approach to Target Non-Coding DNA in Fibrotic Disease Haya Therapeutics, a biotechnology startup, has announced a novel gene-editing strategy to treat fibrotic diseases by targeting non-coding …
Tag:
drug discovery
-
-
Remdesivir for COVID-19: Clinical Efficacy and Current Guidelines Remdesivir, marketed as Veklury, is an antiviral medication administered intravenously to treat COVID-19 in specific patient populations. According to the National Institutes …
-
Researchers have developed a laser-based phase plate for cryo-electron microscopy (cryo-EM) that significantly improves the imaging resolution of small proteins. By using a laser to create a controlled phase shift …
-
Bioengineering Hookworms: A New Frontier in Targeted Drug Delivery In a groundbreaking development for parasitic biology and pharmacology, researchers have successfully engineered the human hookworm, Necator americanus, to produce and …
-
Digital Repression: Understanding the Weaponization of Online Disinformation in Indonesia In the digital age, the intersection of social media and political power has created new avenues for state-led influence. A …
-
Remdesivir: A Comprehensive Guide to the Antiviral Treatment for COVID-19 During the global response to the COVID-19 pandemic, the search for effective therapeutic interventions became a clinical priority. Among the …
-
OICR Advances Next-Generation Cancer Therapies with Modern Funding Developing treatments for hard-to-treat cancers requires a precise balance: increasing the drug’s effectiveness although decreasing its toxicity. The Ontario Institute for Cancer …
-
The Rise of Automated Cell Culture Systems: Scaling the Future of Biopharmaceuticals The transition from manual laboratory techniques to automated cell biology systems is fundamentally reshaping how we develop therapies. …
-
Optibrium Enhances Drug Discovery with AI-Powered Affinity Prediction via New PyMOL Plugin Optibrium, a leading developer of software and AI solutions for molecular design, has announced the release of a …
-
Unlocking Tuberculosis’s Energy Source: A New Path to Treatment Researchers have made a significant breakthrough in understanding how Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), fuels itself during infection. …
Newer Posts